No Data
No Data
Achievements and Progress Heading Into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook
Pfizer's Progress on C. Diff Vaccine and Pneumococcal Shot Wins Analyst Conviction
GSK COVID Antiviral Authorization for Sotrovimab Revoked by FDA
GlaxoSmithKline (GSK) Gets a Hold From Barclays
Express News | GSK Announced Headline Results From FIRST-ENGOT-OV44 Phase 3 Trial Of Zejula (Niraparib) And Jemperli (Dostarlimab) In First Line Advanced Ovarian Cancer, The Trial Met Its Primary Endpoint Of Progression-free Survival, The Key Secondary Endpoint Of...
GSK's Combination of Cancer Drugs Shows Positive Results in Late-Stage Trial
No Data
Youngman : okay what stocks should I keep an eye on in case this happenes?
Jaguar8 OP Youngman : Posted or tagged
Phuong999 : Which one the best ?
Jaguar8 OP Phuong999 : Hmm whichever gets news and buy pressure.